[Diffuse large B-cell lymphoma expressing high-level glyceraldehyde 3-phosphate dehydrogenase complicated with hypoglycemia].

A 69-year-old male patient was referred to our hospital for further examination of hypoglycemia, splenomegaly, and para-aortic lymphadenopathy. The patient was diagnosed with diffuse large B-cell lymphoma (DLBCL) by para-aortic lymph node biopsy. Hypoglycemia was refractory to glucose supplementation but improved shortly after chemotherapy. This situation suggested that hypoglycemia was caused by lymphoma. We compared the expression levels of glyceraldehyde 3-phosphate dehydrogenase, a glycolytic enzyme whose expression is positively correlated with the glycolytic activity of cells, between the current case and two cases of DLBCL without hypoglycemia to explore the possibility that hypoglycemia was due to intense glucose consumption by lymphoma cells through their high glycolytic activity. Results revealed substantially higher expression levels of glyceraldehyde 3-phosphate dehydrogenase in the current case than in DLBCL without hypoglycemia, suggesting that the glycolytic pathway was enhanced in the current case. These results implied that intense glucose consumption by lymphoma cells through their high glycolytic activity causes hypoglycemia.

Biomimetic synthesis of nanostructured WO3 · H2O particles and subsequent thermal conversion to WO3.

Nanostructured tungsten oxide (WO3) particles were prepared in aqueous solution by mimicking biomineralization. Precursor WO3 · H2O particles were generated by ageing a 60°C (NH4)10W12O41 · 5H2O solution containing gelatin. This was followed by heating to 600°C in air for thermal conversion to WO3. The addition of gelatin led to the formation of layered structures consisting of WO3 · H2O platy particles, which contained segmented, block-like nanoscale units. The macroscopic layered structure was preserved after thermal conversion to WO3, while the morphology of the block-like units changed to orthogonally crossed nanorods.